undamentalytics Newsletter

Nuwellis vs Work Medical Technology Group

Work Medical Technology Group is the larger business, with $9.8m of revenue in fiscal 2025 against $8.3m for Nuwellis (1.2 times as much). Nuwellis grew faster (-5.4% against -14.4%). Work Medical Technology Group kept more of each dollar of sales as profit: a net margin of -10.9% against -211.9%. Nuwellis carries less debt relative to equity (0.0% against 34.9%).

Latest fiscal yearNuwellisNUWE, 2025Work Medical Technology GroupWOK, 2025
Revenue $8.3m $9.8m
Revenue growth -5.4% -14.4%
Net income −$17.5m −$1.1m
Operating margin -134.3% —
Net margin -211.9% -10.9%
Return on equity — -6.8%
Free cash flow −$10.9m $4.9m
Cash $1.1m $4.1m
Total debt $0 $6.4m
Debt to equity 0.0% 34.9%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 24 —
Market value $3.2m $30.9m
Price vs our value range — —
Moat score 33 (Weak) —
Insider trades, 12 months 0 buys, 0 sales 10 buys, 5 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.